A detailed history of Panagora Asset Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 48,333 shares of IRWD stock, worth $198,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,333
Holding current value
$198,648
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.93 - $7.04 $189,948 - $340,264
48,333 New
48,333 $198,000
Q4 2022

Feb 13, 2023

SELL
$9.9 - $12.43 $90,941 - $114,181
-9,186 Reduced 19.33%
38,332 $474,000
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $525,073 - $604,428
47,518 New
47,518 $548,000
Q1 2022

May 12, 2022

SELL
$10.61 - $12.88 $281,462 - $341,680
-26,528 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$10.86 - $13.95 $673,591 - $865,248
-62,025 Reduced 70.04%
26,528 $309,000
Q3 2021

Nov 10, 2021

SELL
$11.92 - $13.92 $46,464 - $54,260
-3,898 Reduced 4.22%
88,553 $1.16 Million
Q2 2021

Aug 11, 2021

BUY
$10.16 - $13.11 $939,302 - $1.21 Million
92,451 New
92,451 $1.19 Million
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $1.41 Million - $1.68 Million
-156,339 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$9.14 - $11.97 $1,992 - $2,609
-218 Reduced 0.14%
156,339 $1.61 Million
Q1 2020

May 14, 2020

SELL
$8.58 - $14.01 $3.84 Million - $6.28 Million
-447,949 Reduced 74.1%
156,557 $1.58 Million
Q4 2019

Feb 12, 2020

BUY
$8.22 - $14.0 $1.67 Million - $2.84 Million
202,955 Added 50.54%
604,506 $8.05 Million
Q3 2019

Nov 12, 2019

BUY
$8.59 - $10.96 $78,315 - $99,922
9,117 Added 2.32%
401,551 $3.45 Million
Q2 2019

Aug 09, 2019

BUY
$9.8 - $12.89 $1.34 Million - $1.76 Million
136,815 Added 53.52%
392,434 $4.29 Million
Q1 2019

May 15, 2019

BUY
$8.27 - $12.73 $1.8 Million - $2.76 Million
217,175 Added 564.91%
255,619 $3.46 Million
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $299,863 - $620,101
38,444 New
38,444 $398,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $630M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.